Form 4: Inspire Medical Systems Director Shawn McCormick Reports Stock Award and Trust Disposal

Director Shawn McCormick reports acquisition of restricted stock units and disposal of common stock held in trust.

Summary

• Shawn McCormick, a director of Inspire Medical Systems, Inc., filed a Form 4 detailing changes in beneficial ownership.
• On May 2, 2024, McCormick acquired 716 shares of common stock in the form of Restricted Stock Units (RSUs).
• These RSUs vest on the earlier of the first anniversary of the grant date or immediately prior to a change of control, contingent upon continued employment.
• On the same date, McCormick disposed of 3,000 shares of common stock held indirectly through a trust.
• Following these transactions, McCormick directly owns 12,903 shares of common stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing insider transactions, which has a neutral sentiment.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors often monitor these filings for insights into management's confidence in the company's prospects.

Stakeholder Impact

• The transactions may be of interest to shareholders as they provide insight into the actions of a company director.

Key Dates